SELECT MEDICAL HOLDINGS CORPORATION APPOINTS THOMAS P. MULLIN AS CHIEF EXECUTIVE OFFICER AND ANNOUNCES OTHER CHANGES INVOLVING LONG-TENURED LEADERS
Select Medical Holdings (NYSE: SEM) has announced significant leadership changes, appointing Thomas P. Mullin as its new Chief Executive Officer. Mullin, a 17-year company veteran, previously served as co-president overseeing 140 critical illness recovery and inpatient rehabilitation hospitals.
In concurrent moves, former CEO David S. Chernow has been appointed vice chairman of the board, John A. Saich becomes sole president, and John F. Duggan takes on the role of executive vice president, general counsel and secretary. Additionally, Michael E. Tarvin transitions to senior executive vice president of legal services.
These appointments represent an internal succession plan, with all appointees being long-term company veterans with extensive experience in various leadership roles within Select Medical.
Select Medical Holdings (NYSE: SEM) ha annunciato importanti cambiamenti ai vertici, nominando Thomas P. Mullin nuovo Chief Executive Officer. Mullin, presente in azienda da 17 anni, ricopriva in precedenza il ruolo di co-presidente con responsabilità su 140 strutture per il recupero da malattie critiche e riabilitazione ospedaliera.
Contestualmente, l'ex CEO David S. Chernow è stato nominato vice presidente del consiglio, John A. Saich assume la carica di presidente unico e John F. Duggan diventa executive vice president, general counsel e segretario. Inoltre, Michael E. Tarvin passa al ruolo di senior executive vice president dei servizi legali.
Le nomine costituiscono un piano di successione interna: tutti i designati sono dirigenti di lunga data dell’azienda con ampia esperienza in diversi ruoli di leadership all'interno di Select Medical.
Select Medical Holdings (NYSE: SEM) ha anunciado cambios relevantes en su liderazgo, nombrando a Thomas P. Mullin como su nuevo Chief Executive Officer. Mullin, veterano de la compañía con 17 años, había sido co-presidente a cargo de 140 hospitales de recuperación por enfermedades críticas y de rehabilitación para pacientes hospitalizados.
De forma simultánea, el ex CEO David S. Chernow ha sido designado vicepresidente del consejo, John A. Saich pasa a ser presidente único y John F. Duggan asume el cargo de executive vice president, general counsel y secretario. Además, Michael E. Tarvin se incorpora como senior executive vice president de servicios legales.
Estos nombramientos forman parte de un plan de sucesión interna; todos los designados son veteranos de larga trayectoria en la compañía con amplia experiencia en diversos puestos directivos dentro de Select Medical.
Select Medical Holdings (NYSE: SEM)이 주요 경영진 변화를 발표하며 Thomas P. Mullin을 신임 최고경영자(CEO)로 선임했습니다. Mullin은 17년간 회사에 재직해왔으며, 이전에는 140곳의 중증 질환 회복 및 입원 재활 병원을 총괄하는 공동 사장을 맡았습니다.
동시에 전 CEO인 David S. Chernow는 이사회 부회장으로, John A. Saich는 단독 사장으로, John F. Duggan은 executive vice president 겸 general counsel 및 서기(Secretary)로 임명되었습니다. 또한 Michael E. Tarvin은 법무 서비스 총괄인 senior executive vice president로 자리를 옮깁니다.
이들 임명은 내부 승계 계획의 일환으로, 모두 Select Medical에서 오랜 기간 근무하며 다양한 리더십 역할을 수행해온 내부 인사들입니다.
Select Medical Holdings (NYSE: SEM) a annoncé d'importants changements à sa direction en nommant Thomas P. Mullin nouveau Chief Executive Officer. Mullin, employé depuis 17 ans, occupait auparavant la co-présidence et supervisait 140 établissements de rétablissement après maladies graves et de réadaptation hospitalière.
Parallèlement, l'ancien CEO David S. Chernow est nommé vice-président du conseil, John A. Saich devient président unique et John F. Duggan assume les fonctions d'executive vice president, general counsel et secrétaire. De plus, Michael E. Tarvin est promu senior executive vice president des services juridiques.
Ces nominations s'inscrivent dans un plan de succession interne : tous les nommés sont des cadres de longue date de l'entreprise, possédant une large expérience de divers rôles de direction au sein de Select Medical.
Select Medical Holdings (NYSE: SEM) hat bedeutende Führungswechsel angekündigt und Thomas P. Mullin zum neuen Chief Executive Officer ernannt. Mullin ist seit 17 Jahren im Unternehmen und war zuvor Co-President mit Verantwortung für 140 Krankenhäuser zur Genesung von schweren Erkrankungen und stationärer Rehabilitation.
Gleichzeitig wurde der frühere CEO David S. Chernow zum Vice Chairman des Vorstands ernannt, John A. Saich wird alleiniger President und John F. Duggan übernimmt die Position des Executive Vice President, General Counsel und Secretary. Darüber hinaus wechselt Michael E. Tarvin in die Rolle des Senior Executive Vice President für Rechtsangelegenheiten.
Bei diesen Ernennungen handelt es sich um einen internen Nachfolgeplan: Alle Berufenen sind langjährige Unternehmensveteranen mit umfassender Erfahrung in verschiedenen Führungsfunktionen bei Select Medical.
- All new appointees are long-term company veterans with 17-27 years of experience
- Smooth internal succession planning demonstrates strong leadership development
- Continuity in management with experienced executives taking key positions
- Significant simultaneous leadership changes may create temporary organizational adjustment period
Mr. Mullin joined Select Medical in 2008, most recently serving as co-president overseeing 140 critical illness recovery and inpatient rehabilitation hospitals and the expansive growth of both divisions nationwide. Over his 17 years with the company, Mr. Mullin has held executive leadership roles of increasing responsibility including executive vice president from 2020-2023, president of specialty hospitals from 2018-2020, and chief operating officer of specialty hospitals from 2016-2018. Prior to his divisional appointments, Mr. Mullin held a variety of leadership positions in the Critical Illness Recovery Hospital Division, including senior vice president of business and market development, and regional vice president. Earlier in his Select Medical career, Mr. Mullin held operational positions at the hospital level in the division.
Mr. Chernow has been appointed vice chairman of the board after serving as the company's chief executive officer since 2014. Previously, he served as president and chief executive officer from 2014-2023 and as president and chief strategy officer from 2010-2014. Prior to Mr. Chernow's corporate officer posts, he joined the board of directors of Select Medical Corporation in 2002 and was an independent director of that company for nearly a decade.
Mr. Saich, who has held the post of co-president since 2023, will serve as the sole president of Select Medical. He will retain oversight of outpatient rehabilitation and shared services operations while taking on expanded responsibilities across the organization. Previously, Mr. Saich served as executive vice president and chief administrative officer from 2018-2023 and held a variety of senior human resources leadership positions spanning his 27 years with the company.
Mr. Duggan, a 25-year Select Medical veteran, has been appointed executive vice president, general counsel and secretary after serving as executive vice president and deputy general counsel since 2023. Previously, Mr. Duggan held the posts of senior vice president and senior counsel from 2007-2023, vice president and senior counsel from 2002-2007, and associate counsel from 2000-2002.
Michael E. Tarvin has served as senior executive vice president, general counsel and secretary since 2023, as executive vice president, general counsel and secretary from 2007-2023, as senior vice president, general counsel and secretary from 1999-2007, and as vice president, general counsel and secretary from 1997-1999. Mr. Tarvin will transition to his new post as senior executive vice president of legal services.
"Select Medical has always placed a high priority on the development and growth of its people as a means to drive the future success of the company," said Select Medical Co-Founder and Executive Chairman Robert A. Ortenzio. "The appointments of these long-time veterans with impeccable track records underscores our commitment to our values, vision and mission. I could not be more proud to see Select Medical's succession planning process working with the appointment of these next generation leaders, each with decades of experience at the company. I look forward to continuing to work closely with these top-notch executives as we execute against an aggressive growth strategy that provides patients with access to world-class post-acute care across the country and delivers value to our stockholders."
About Select Medical
Select Medical is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in
Media inquiries:
Shelly Eckenroth
seckenroth@selectmedical.com
717-920-4035
Investor inquiries:
Joel T. Veit
ir@selectmedical.com
717-972-1100
View original content:SOURCE Select Medical Holdings Corporation
FAQ
Who is the new CEO of Select Medical Holdings (NYSE: SEM)?
What happened to Select Medical's previous CEO David Chernow?
What experience does Thomas Mullin have at Select Medical?
What other leadership changes were announced at Select Medical (SEM)?
How many hospitals does Select Medical operate?
